scholarly journals Predictive biomarkers for immune checkpoint inhibitor therapy: we need to keep searching

2018 ◽  
Vol 10 (S18) ◽  
pp. S2195-S2197 ◽  
Author(s):  
Mary M. Huerter ◽  
Apar Kishor Ganti
Keyword(s):  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitor ◽  
Checkpoint Inhibitor ◽  
Predictive Biomarkers ◽  
Inhibitor Therapy ◽  
Checkpoint Inhibitor Therapy

Biomarkers of hyperprogression and pseudoprogression with immune checkpoint inhibitor therapy

2019 ◽  
Vol 15 (22) ◽  
pp. 2645-2656 ◽  
Author(s):  
Jarrett J Failing ◽  
Olivia A Dudek ◽  
Julian A Marin Acevedo ◽  
Razvan M Chirila ◽  
Haidong Dong ◽  
...  
Keyword(s):  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitor ◽  
Checkpoint Inhibitor ◽  
Unmet Need ◽  
Predictive Biomarkers ◽  
Small Sample ◽  
Inhibitor Therapy ◽  
Laboratory Findings ◽  
Therapeutic Decisions ◽  
Checkpoint Inhibitor Therapy

Hyperprogression and pseudoprogression are two atypical responses to immune checkpoint inhibitor therapy that affect therapeutic decisions and prognosis. Identification of predictive biomarkers for atypical responses either before or during treatment remains a huge unmet need in cancer immunotherapy. Many studies have looked at potential biomarkers, including clinical factors and laboratory findings (e.g., peripheral blood counts, circulating tumor DNA, cytokine levels). The results of these studies have been inconsistent, possibly due to small sample sizes, different tumor types and heterogeneity of the definition of these atypical responses.

A Systematic Review of Cases of Diabetes Mellitus following Immune Checkpoint Inhibitor Therapy for Cancer

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 204-LB ◽  
Author(s):  
KARA R. MIZOKAMI-STOUT ◽  
ROMA GIANCHANDANI ◽  
MARK MACEACHERN ◽  
RAVI M. IYENGAR ◽  
SARAH YENTZ ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitor ◽  
Checkpoint Inhibitor ◽  
Inhibitor Therapy ◽  
Checkpoint Inhibitor Therapy

scholarly journals Collaboration Between Rheumatology and Oncology in Immune Checkpoint Inhibitor Therapy

2018 ◽  
Vol 36 (26) ◽  
pp. 2743-2744 ◽  
Author(s):  
Donald L. Kimpel ◽  
Janet E. Lewis ◽  
Elizabeth Gaughan ◽  
William W. Grosh ◽  
Christiana Brenin
Keyword(s):  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitor ◽  
Checkpoint Inhibitor ◽  
Inhibitor Therapy ◽  
Checkpoint Inhibitor Therapy

scholarly journals Neurotoxicities associated with immune checkpoint inhibitor therapy

2021 ◽  
Author(s):  
Sophie L. Duong ◽  
Frank J. Barbiero ◽  
Richard J. Nowak ◽  
Joachim M. Baehring
Keyword(s):  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitor ◽  
Checkpoint Inhibitor ◽  
Inhibitor Therapy ◽  
Checkpoint Inhibitor Therapy

Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses

2021 ◽  
pp. 1-21
Author(s):  
Thomas K. Le ◽  
Subuhi Kaul ◽  
Laura C. Cappelli ◽  
Jarushka Naidoo ◽  
Yevgeniy R. Semenov ◽  
...  
Keyword(s):  
Adverse Events ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitor ◽  
Checkpoint Inhibitor ◽  
Inhibitor Therapy ◽  
Checkpoint Inhibitor Therapy

scholarly journals Immune‐Related Hematologic Adverse Events in the Context of Immune Checkpoint Inhibitor Therapy

2021 ◽  
Author(s):  
Antoine N. Saliba ◽  
Zhuoer Xie ◽  
Alexandra S. Higgins ◽  
Xavier A. Andrade‐Gonzalez ◽  
Harry E. Fuentes‐Bayne ◽  
...  
Keyword(s):  
Adverse Events ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitor ◽  
Checkpoint Inhibitor ◽  
Inhibitor Therapy ◽  
Checkpoint Inhibitor Therapy
Sign in / Sign up

Export Citation Format

Share Document